Subacute Toxicity of Combined Vaccine (KGCC-95VI) Against Japanese Encephalitis and Hantaan Virus Infection in Rabbits

  • Shin, Kwang-Soon (College of Veterinary Medicine, Chungnam National University) ;
  • Cho, Sung-Hwan (College of Veterinary Medicine, Chungnam National University) ;
  • Yun, Hyo-In (College of Veterinary Medicine, Chungnam National University) ;
  • Kim, Chul-Joong (College of Veterinary Medicine, Chungnam National University) ;
  • Shin, Hyun-Jin (College of Veterinary Medicine, Chungnam National University) ;
  • Nam, Sang-Min (College of Veterinary Medicine, Chungnam National University) ;
  • Park, Young-Mi (College of Veterinary Medicine, Chungnam National University) ;
  • Choi, Eun-Ah (College of Veterinary Medicine, Chungnam National University) ;
  • Kim, Eun (College of Veterinary Medicine, Chungnam National University) ;
  • Youn, Won-Ki (College of Veterinary Medicine, Chungnam National University) ;
  • Sohn, Hwa-Young (College of Veterinary Medicine, Chungnam National University) ;
  • Song, Dong-Ho (Central Resrarch Institute, Korea Green Cross Corp.,) ;
  • Park, Jong-Il (Toxicology, Research centr, KRICT) ;
  • Cha, Shin-Woo (Toxicology, Research centr, KRICT) ;
  • Ahn, Chang-Nam (Central Resrarch Institute, Korea Green Cross Corp.,) ;
  • Shin, Hyeong-Soon (Dept. of Biotechnology, Inha Univ.)
  • Published : 1997.09.01

Abstract

The subacute toxicity of the combined vaccine (KGCC-95VI) for the prophylaxis against Japanese encephalitis and Hantaan virus infection, recently developed by Korea Green Cross Corporation, was investigated. KGCC-95VI was subcutaneously administered into the both sexes of New Zealand White rabbits at the dosage of 0, 10. 50 and 250 ml/kg body weight (20, 100 and 500 times the expected clincal dose) once a day for 30 days. There were no deaths and clinical findings during the experiment period. In both sexes. there were no statistically significant differences between the treated and control groups in urinalysis tests, hematological tests, blood chemistry tests and pathological examinations. The KGCC-95VI is considered not to have the subacute toxicity in the rabbits.

Keywords

References

  1. Am J Trop Med Hyg v.8 Ecological studies of Japanese encephalitis in Japan Buescher, E.L.;Scherer, W.F.
  2. Report of NIH, Kor v.31 An tigenic analysis of JE virus isolated from mosquitos(C. t)in Korea and development of a rapid diagnosis for JE by using monoclonal antibody Cho, H.W.;Kim, C.L.;Ban, Nam, J.H.
  3. J. Inf. Dis. v.168 The children'vaccine initiative-will it work? Douglas, R.G.
  4. FDA, Korea, Provision #1996-8 Guidelines for Safety Tests of Drugs
  5. New Engl. J. of Med. v.319 Protection against Japanese encephalitis by inactivated vaccine Hoke, C.H.;Nisalak, A.;Sagawhipa, N.
  6. J. Korean Soc. Virol. v.18 Development of Vaccine against Hemorrhagic Fever with Renal Syndrome Lee, H.W.;Ahn, C.N.
  7. Korean J. Toxicol v.11 Subacute Toxicity of HRccine (HFRS-virus vaccine) in Rabbits Lim, D.M.;Baik, Y.O.;Cho, H.J.;Choi, J.M.;Kim, D.H.;Park, KH.;Cho, J.S.;Lee, Y.S.
  8. WHO report Guidelines for mass immunization using Japanese encephalitis vaccines Oya, A.
  9. J. Korean Soc. Microbiol. v.27 Study on the ELISA method using monoclonal antibody for the detection of Hantaan virus Shin, K.S.
  10. Bull WHO v.63 Japanese encephalitis: current world-wide status Umenai, T.;Krzyko, R.;Bektimirov, T.A.
  11. Vaccine v.6 Development of inactivatedvaccine against virus causing hemorrhagic fever with renal syndrome Yamanishi, K.;Tomishita, O.;Tamura, M.